Asymmetry Capital Management, L.P.
CIK
1657134
Location
SAN FRANCISCO, CA
Portfolio Value
Small
$136,409,760
Diversification
Diversified
Filing Date
Global Rank
#4,101
/ 6,772
▲ 231
Top Industry
Biotechnology
44.2%
3Y Alpha vs SPY
-10.9%
Period ended 4 years ago
Filed Jan 19, 2022 · 4y
8 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+32.8%
SPY
+76.3%
Annualised alpha
-10.9%
Max drawdown
−28.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
15 positions · as of Dec 31, 2021 · Δ vs Sep 30, 2021Top Position
11.5%
−0.6 pts
Top 5
48.9%
−5.1 pts
Top 10
81.8%
−6.3 pts
HHI
779
Diversified−96
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2021| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $136,409,760 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
4 positions
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 177,741 | $15,703,417 | |
| UNH | Unitedhealth Group Inc | 26,844 | $13,479,446 | |
| ABBV | AbbVie Inc. | 94,448 | $12,788,259 | |
| IQV | Iqvia Holdings Inc. | 44,314 | $12,502,751 | |
| CNC | Centene Corp | 148,254 | $12,216,129 | |
| JNJ | Johnson & Johnson | 55,755 | $9,538,007 | |
| NTRA | Natera, Inc. | 101,674 | $9,495,334 | |
| ARGX | Argenx SE | 20,881 | $7,312,317 | |
| APLS | Apellis Pharmaceuticals, Inc. | 139,445 | $6,592,959 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALKS | Alkermes plc. | 373,382 | $11,515,100 | |
| MDT | Medtronic plc | 83,737 | $10,496,432 | |
| PODD | Insulet Corp | 36,732 | $10,440,336 | |
| HOLX | HOLOGIC INC | 138,884 | $10,251,028 | |
| PTCT | Ptc Therapeutics, Inc. | 215,985 | $8,036,801 | |
| KYMR | Kymera Therapeutics, Inc. | 89,071 | $5,232,030 | |
| BAX | Baxter International Inc | 61,570 | $4,952,075 | |
| LRMR | Larimar Therapeutics, Inc. | 34,943 | $402,892 | |
| No positions match the current search. | ||||
15 positions ·
$136,409,760 total
· as of Dec 31, 2021
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 177,741 | $15,703,417 | 11.51% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 26,844 | $13,479,446 | 9.88% | |
| ABBV |
AbbVie Inc.
Healthcare
|
NEW | 94,448 | $12,788,259 | 9.37% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
NEW | 44,314 | $12,502,751 | 9.17% | |
| CNC |
Centene Corp
Healthcare
|
NEW | 148,254 | $12,216,129 | 8.96% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 225,032 | $10,256,958 | 7.52% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 55,755 | $9,538,007 | 6.99% | |
| NTRA |
Natera, Inc.
Healthcare
|
NEW | 101,674 | $9,495,334 | 6.96% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Added | 716,709 | $8,277,988 | 6.07% | |
| ARGX |
Argenx SE
Healthcare
|
NEW | 20,881 | $7,312,317 | 5.36% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 502,275 | $7,031,850 | 5.15% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
NEW | 139,445 | $6,592,959 | 4.83% | |
| QTRX |
Quanterix Corp
Healthcare
|
Reduced | 143,204 | $6,071,849 | 4.45% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Reduced | 198,493 | $2,886,088 | 2.12% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Reduced | 97,680 | $2,256,408 | 1.65% |